{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T04:13:17Z","timestamp":1750219997710,"version":"3.41.0"},"publisher-location":"New York, NY, USA","reference-count":27,"publisher":"ACM","license":[{"start":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T00:00:00Z","timestamp":1635465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.acm.org\/publications\/policies\/copyright_policy#Background"}],"content-domain":{"domain":["dl.acm.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,10,29]]},"DOI":"10.1145\/3500931.3500989","type":"proceedings-article","created":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T05:13:49Z","timestamp":1640236429000},"page":"330-334","update-policy":"https:\/\/doi.org\/10.1145\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["How the Medicine Works for Treat the Depression"],"prefix":"10.1145","author":[{"given":"Xiangke","family":"Zhang","sequence":"first","affiliation":[{"name":"College of science, Purdue University, West Lafayette, United States"}]}],"member":"320","published-online":{"date-parts":[[2021,12,22]]},"reference":[{"key":"e_1_3_2_1_1_1","volume-title":"M.D., Brad A. Alford, Ph.D. https:\/\/www.upenn.edu\/pennpress\/book\/14502.html.","author":"Beck A. T.","year":"1967","unstructured":"Beck , A. T. ( 1967 ). DepressionCauses and treatment. Depression | Aaron T. Beck , M.D., Brad A. Alford, Ph.D. https:\/\/www.upenn.edu\/pennpress\/book\/14502.html. Beck, A. T. (1967). DepressionCauses and treatment. Depression | Aaron T. Beck, M.D., Brad A. Alford, Ph.D. https:\/\/www.upenn.edu\/pennpress\/book\/14502.html."},{"issue":"2","key":"e_1_3_2_1_2_1","first-page":"77","article-title":"Aaron Temkin Beck (born July 18, 1921-) Biography","volume":"1","author":"Fatih Yavuz M.","year":"2012","unstructured":"K. Fatih Yavuz , & M. Hakan T\u00fcrk\u00e7apar . ( 2012 ). Aaron Temkin Beck (born July 18, 1921-) Biography . Journal of Cognitive-behavioral Psychotherapy and Research , 1 ( 2 ), 77 -- 80 . https:\/\/doaj.org\/article\/63bd59bf2cae4cdca3def118471a2bee. K. Fatih Yavuz, & M. Hakan T\u00fcrk\u00e7apar. (2012). Aaron Temkin Beck (born July 18, 1921-) Biography. Journal of Cognitive-behavioral Psychotherapy and Research, 1(2), 77--80. https:\/\/doaj.org\/article\/63bd59bf2cae4cdca3def118471a2bee.","journal-title":"Journal of Cognitive-behavioral Psychotherapy and Research"},{"key":"e_1_3_2_1_3_1","volume-title":"The importance of norepinephrine in depression. Neuropsychiatric disease and treatment. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3131098\/","author":"Moret C.","year":"2011","unstructured":"Moret , C. , & Briley , M. ( 2011 ). The importance of norepinephrine in depression. Neuropsychiatric disease and treatment. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3131098\/ . Moret, C., & Briley, M. (2011). The importance of norepinephrine in depression. Neuropsychiatric disease and treatment. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3131098\/."},{"key":"e_1_3_2_1_4_1","volume-title":"Interpretation of drug therapy of Chinese Guidelines for Prevention and Treatment of Depression. Wanfang medicine","author":"Niu Y.","year":"2018","unstructured":"Niu , Y. ( 2018 ). Interpretation of drug therapy of Chinese Guidelines for Prevention and Treatment of Depression. Wanfang medicine . http:\/\/med.wanfangdata.com.cn\/Paper\/Detail?id=PeriodicalPaper_lcywzlzz201805002&dbid=WF_QK. Niu, Y. (2018). Interpretation of drug therapy of Chinese Guidelines for Prevention and Treatment of Depression. Wanfang medicine. http:\/\/med.wanfangdata.com.cn\/Paper\/Detail?id=PeriodicalPaper_lcywzlzz201805002&dbid=WF_QK."},{"key":"e_1_3_2_1_5_1","volume-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories","author":"Spencer L, J","year":"2017","unstructured":"Spencer L, J . ( 2017 ). Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories , 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Redirecting . https:\/\/doi.org\/10.1016\/S0140-6736(18)32279-7. 10.1016\/S0140-6736(18)32279-7 Spencer L, J. (2017). Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Redirecting. https:\/\/doi.org\/10.1016\/S0140-6736(18)32279-7."},{"key":"e_1_3_2_1_6_1","article-title":"Why is depression more prevalent in women","author":"Albert P. R.","year":"2015","unstructured":"Albert , P. R. ( 2015 ). Why is depression more prevalent in women ? Journal of psychiatry & neuroscience: JPN. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4478054\/. Albert, P. R. (2015). Why is depression more prevalent in women? Journal of psychiatry & neuroscience: JPN. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4478054\/.","journal-title":"Journal of psychiatry & neuroscience: JPN. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4478054\/."},{"key":"e_1_3_2_1_7_1","volume-title":"Depression","author":"World Health Organization","year":"2020","unstructured":"World Health Organization . ( 2020 ). Depression . World Health Organization . https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/depression. World Health Organization. (2020). Depression. World Health Organization. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/depression."},{"key":"e_1_3_2_1_8_1","doi-asserted-by":"crossref","unstructured":"Pearl T. A. Dumkrieger G. Chong C. D. Dodick D. W. & Schwedt T. J. (2020). Impact of depression and anxiety symptoms on patient-reported outcomes in patients With Migraine: Results from the American registry for MIGRAINE Research (armr). Headache. https:\/\/pubmed.ncbi.nlm.nih.gov\/32749685\/.  Pearl T. A. Dumkrieger G. Chong C. D. Dodick D. W. & Schwedt T. J. (2020). Impact of depression and anxiety symptoms on patient-reported outcomes in patients With Migraine: Results from the American registry for MIGRAINE Research (armr). Headache. https:\/\/pubmed.ncbi.nlm.nih.gov\/32749685\/.","DOI":"10.1111\/head.13911"},{"key":"e_1_3_2_1_9_1","volume-title":"The first national action plan on depression in China: Progress and challenges. Define_me. https:\/\/www.thelancet.com\/journals\/lanwpc\/article\/PIIS2666-6065(20)30078-X\/fulltext","author":"Wen L.","year":"2021","unstructured":"Wen , L. , Yuan , Y. , ZiHan , L. , YanJie , Z. , Ling , Z. , & Teris , C. ( 2021 ). The first national action plan on depression in China: Progress and challenges. Define_me. https:\/\/www.thelancet.com\/journals\/lanwpc\/article\/PIIS2666-6065(20)30078-X\/fulltext . Wen, L., Yuan, Y., ZiHan, L., YanJie, Z., Ling, Z., & Teris, C. (2021). The first national action plan on depression in China: Progress and challenges. Define_me. https:\/\/www.thelancet.com\/journals\/lanwpc\/article\/PIIS2666-6065(20)30078-X\/fulltext."},{"key":"e_1_3_2_1_10_1","unstructured":"Depression2021. Mental Health America. (2021). https:\/\/www.mhanational.org\/conditions\/depression.  Depression2021. Mental Health America. (2021). https:\/\/www.mhanational.org\/conditions\/depression."},{"key":"e_1_3_2_1_11_1","volume-title":"Search drugs and targets: Therapeutic target database. Search drugs and targets | Therapeutic Target Database","author":"Wan Y. X.","year":"2021","unstructured":"Wan , Y. X. ( 2021 ). Search drugs and targets: Therapeutic target database. Search drugs and targets | Therapeutic Target Database . http:\/\/db.idrblab.net\/ttd\/search\/ttd\/disease?search_api_fulltext=depression&page=0. Wan, Y. X. (2021). Search drugs and targets: Therapeutic target database. Search drugs and targets | Therapeutic Target Database. http:\/\/db.idrblab.net\/ttd\/search\/ttd\/disease?search_api_fulltext=depression&page=0."},{"key":"e_1_3_2_1_12_1","unstructured":"Wong D. T. Bymaster F. P. & Engleman E. A. (2000). Prozac (FLUOXETINE lilly 110140) the First selective serotonin uptake inhibitor and an Antidepressant DRUG: Twenty years since its first publication. Life Sciences. https:\/\/www.sciencedirect.com\/science\/article\/pii\/002432059500209O?via%3Dihub.  Wong D. T. Bymaster F. P. & Engleman E. A. (2000). Prozac (FLUOXETINE lilly 110140) the First selective serotonin uptake inhibitor and an Antidepressant DRUG: Twenty years since its first publication. Life Sciences. https:\/\/www.sciencedirect.com\/science\/article\/pii\/002432059500209O?via%3Dihub."},{"key":"e_1_3_2_1_13_1","first-page":"3","article-title":"A selective inhibitor of serotonin uptake","volume":"110140","author":"Wong D. T.","year":"2002","unstructured":"Wong , D. T. , Horng , J. S. , Bymaster , F. P. , Hauser , K. L. , & Molloy , B. B. ( 2002 ). A selective inhibitor of serotonin uptake : Lilly 110140 , 3 -(p-trifluoromethylphenoxy)-n-methyl-3-phenylpropylamine. Life Sciences. https:\/\/www.sciencedirect.com\/science\/article\/pii\/0024320574903452?via%3Dihub. Wong, D. T., Horng, J. S., Bymaster, F. P., Hauser, K. L., & Molloy, B. B. (2002). A selective inhibitor of serotonin uptake: Lilly 110140, 3-(p-trifluoromethylphenoxy)-n-methyl-3-phenylpropylamine. Life Sciences. https:\/\/www.sciencedirect.com\/science\/article\/pii\/0024320574903452?via%3Dihub.","journal-title":"Lilly"},{"key":"e_1_3_2_1_14_1","unstructured":"Restorative health - history of ketamine. Restorative Health - History of Ketamine. (2021). https:\/\/www.restorativehealthprimarycare.com\/about\/published-articles\/history-of-ketamine.  Restorative health - history of ketamine. Restorative Health - History of Ketamine. (2021). https:\/\/www.restorativehealthprimarycare.com\/about\/published-articles\/history-of-ketamine."},{"key":"e_1_3_2_1_15_1","volume-title":"Fluoxetine","author":"U.S. National Library of Medicine.","year":"2021","unstructured":"U.S. National Library of Medicine. ( 2021 ). Fluoxetine . National Center for Biotechnology Information . PubChem Compound Database. https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Fluoxetine. U.S. National Library of Medicine. (2021). Fluoxetine. National Center for Biotechnology Information. PubChem Compound Database. https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Fluoxetine."},{"key":"e_1_3_2_1_16_1","volume-title":"Ketamine","author":"U.S. National Library of Medicine.","year":"2021","unstructured":"U.S. National Library of Medicine. ( 2021 ). Ketamine . National Center for Biotechnology Information . PubChem Compound Database. https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Ketamine. U.S. National Library of Medicine. (2021). Ketamine. National Center for Biotechnology Information. PubChem Compound Database. https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Ketamine."},{"key":"e_1_3_2_1_17_1","volume-title":"Case history: The discovery of fluoxetine hydrochloride (prozac). Nature reviews. Drug discovery. https:\/\/pubmed.ncbi.nlm.nih.gov\/16121130\/","author":"Wong D.T.","year":"2005","unstructured":"Wong D.T. , Perry K.W. , Bymaster F.P. ( 2005 ). Case history: The discovery of fluoxetine hydrochloride (prozac). Nature reviews. Drug discovery. https:\/\/pubmed.ncbi.nlm.nih.gov\/16121130\/ . Wong D.T., Perry K.W., Bymaster F.P. (2005). Case history: The discovery of fluoxetine hydrochloride (prozac). Nature reviews. Drug discovery. https:\/\/pubmed.ncbi.nlm.nih.gov\/16121130\/."},{"key":"e_1_3_2_1_18_1","volume-title":"https:\/\/www.tocris.com\/pharmacology\/5-ht-transporters","author":"Pharmacology","year":"2021","unstructured":"Pharmacology . Tocris Bioscience. ( 2021 ). https:\/\/www.tocris.com\/pharmacology\/5-ht-transporters . Pharmacology. Tocris Bioscience. (2021). https:\/\/www.tocris.com\/pharmacology\/5-ht-transporters."},{"key":"e_1_3_2_1_19_1","volume-title":"Sodium-dependent serotonin transporter","author":"UniProt ConsortiumEuropean Bioinformatics InstituteProtein Information ResourceSIB Swiss Institute of Bioinformatics.","year":"2021","unstructured":"UniProt ConsortiumEuropean Bioinformatics InstituteProtein Information ResourceSIB Swiss Institute of Bioinformatics. ( 2021 ). Sodium-dependent serotonin transporter . UniProt ConsortiumEuropean Bioinformatics InstituteProtein Information ResourceSIB Swiss Institute of Bioinformatics . https:\/\/www.uniprot.org\/uniprot\/P31645. UniProt ConsortiumEuropean Bioinformatics InstituteProtein Information ResourceSIB Swiss Institute of Bioinformatics. (2021). Sodium-dependent serotonin transporter. UniProt ConsortiumEuropean Bioinformatics InstituteProtein Information ResourceSIB Swiss Institute of Bioinformatics. https:\/\/www.uniprot.org\/uniprot\/P31645."},{"key":"e_1_3_2_1_20_1","volume-title":"How antidepressants block serotonin transport. ALS. https:\/\/als.lbl.gov\/antidepressants-block-serotonin-transport\/","author":"Coleman J.","year":"2020","unstructured":"Coleman , J. , & Gouaux , E. ( 2020 ). How antidepressants block serotonin transport. ALS. https:\/\/als.lbl.gov\/antidepressants-block-serotonin-transport\/ . Coleman, J., & Gouaux, E. (2020). How antidepressants block serotonin transport. ALS. https:\/\/als.lbl.gov\/antidepressants-block-serotonin-transport\/."},{"key":"e_1_3_2_1_21_1","volume-title":"Fluoxetine hydrochloride. Retrieved","author":"National Center for Biotechnology Information","year":"2021","unstructured":"National Center for Biotechnology Information ( 2021 ). PubChem Compound LCSS for CID 62857 , Fluoxetine hydrochloride. Retrieved August 3, 2021 from https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Fluoxetine-hydrochloride#datasheet=LCSS. National Center for Biotechnology Information (2021). PubChem Compound LCSS for CID 62857, Fluoxetine hydrochloride. Retrieved August 3, 2021 from https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Fluoxetine-hydrochloride#datasheet=LCSS."},{"key":"e_1_3_2_1_22_1","volume-title":"Side effects of prozac (fluoxetine hcl), warnings, uses. RxList. https:\/\/www.rxlist.com\/prozac-side-effects-drug-center.htm#consumer","author":"Cunha J. O. H. N. P.","year":"2020","unstructured":"Cunha , J. O. H. N. P. ( 2020 ). Side effects of prozac (fluoxetine hcl), warnings, uses. RxList. https:\/\/www.rxlist.com\/prozac-side-effects-drug-center.htm#consumer . Cunha, J. O. H. N. P. (2020). Side effects of prozac (fluoxetine hcl), warnings, uses. RxList. https:\/\/www.rxlist.com\/prozac-side-effects-drug-center.htm#consumer."},{"key":"e_1_3_2_1_23_1","volume-title":"Ketamine steps out of the darkness. Nature News. https:\/\/www.nature.com\/articles\/nature17897","author":"Malinow R.","year":"2016","unstructured":"Malinow , R. ( 2016 ). Ketamine steps out of the darkness. Nature News. https:\/\/www.nature.com\/articles\/nature17897 . Malinow, R. (2016). Ketamine steps out of the darkness. Nature News. https:\/\/www.nature.com\/articles\/nature17897."},{"key":"e_1_3_2_1_24_1","volume-title":"Ampa receptor trafficking for postsynaptic potentiation. Frontiers. https:\/\/www.frontiersin.org\/articles\/10.3389\/fncel.2018.00361\/full","author":"Park M.","year":"2018","unstructured":"Park , M. ( 2018 ). Ampa receptor trafficking for postsynaptic potentiation. Frontiers. https:\/\/www.frontiersin.org\/articles\/10.3389\/fncel.2018.00361\/full . Park, M. (2018). Ampa receptor trafficking for postsynaptic potentiation. Frontiers. https:\/\/www.frontiersin.org\/articles\/10.3389\/fncel.2018.00361\/full."},{"key":"e_1_3_2_1_25_1","volume-title":"Depression and other mental health diagnoses increase mortality risk after ischemic stroke. American Journal of Psychiatry. https:\/\/ajp.psychiatryonline.org\/doi\/full\/10.1176\/appi.ajp.161.6.1090","author":"Williams L. S.","year":"2004","unstructured":"Williams , L. S. , Ghose , S. S. , Swindle , R. W. , & Robinson , R. G. ( 2004 ). Depression and other mental health diagnoses increase mortality risk after ischemic stroke. American Journal of Psychiatry. https:\/\/ajp.psychiatryonline.org\/doi\/full\/10.1176\/appi.ajp.161.6.1090 . Williams, L. S., Ghose, S. S., Swindle, R. W., & Robinson, R. G. (2004). Depression and other mental health diagnoses increase mortality risk after ischemic stroke. American Journal of Psychiatry. https:\/\/ajp.psychiatryonline.org\/doi\/full\/10.1176\/appi.ajp.161.6.1090."},{"key":"e_1_3_2_1_26_1","volume-title":"Adverse events associated with ketamine for procedural sedation in adults. The American Journal of Emergency Medicine. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S073567570800020X?via%3Dihub","author":"Strayer R. J.","year":"2008","unstructured":"Strayer , R. J. , & Nelson , L. S. ( 2008 ). Adverse events associated with ketamine for procedural sedation in adults. The American Journal of Emergency Medicine. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S073567570800020X?via%3Dihub . Strayer, R. J., & Nelson, L. S. (2008). Adverse events associated with ketamine for procedural sedation in adults. The American Journal of Emergency Medicine. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S073567570800020X?via%3Dihub."},{"key":"e_1_3_2_1_27_1","volume-title":"Fluoxetine hydrochloride capsule was approved for the treatment of depression by conformance evaluation. Beijing News - Good news, endless. https:\/\/www.bjnews.com.cn\/detail\/158409970815439.html","author":"Liu X.","year":"2020","unstructured":"Liu , X. ( 2020 ). Fluoxetine hydrochloride capsule was approved for the treatment of depression by conformance evaluation. Beijing News - Good news, endless. https:\/\/www.bjnews.com.cn\/detail\/158409970815439.html . Liu, X. (2020). Fluoxetine hydrochloride capsule was approved for the treatment of depression by conformance evaluation. Beijing News - Good news, endless. https:\/\/www.bjnews.com.cn\/detail\/158409970815439.html."}],"event":{"name":"ISAIMS 2021: 2nd International Symposium on Artificial Intelligence for Medicine Sciences","acronym":"ISAIMS 2021","location":"Beijing China"},"container-title":["Proceedings of the 2nd International Symposium on Artificial Intelligence for Medicine Sciences"],"original-title":[],"link":[{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/3500931.3500989","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dl.acm.org\/doi\/pdf\/10.1145\/3500931.3500989","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T17:50:52Z","timestamp":1750182652000},"score":1,"resource":{"primary":{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/3500931.3500989"}},"subtitle":["Prozac and Ketamine"],"short-title":[],"issued":{"date-parts":[[2021,10,29]]},"references-count":27,"alternative-id":["10.1145\/3500931.3500989","10.1145\/3500931"],"URL":"https:\/\/doi.org\/10.1145\/3500931.3500989","relation":{},"subject":[],"published":{"date-parts":[[2021,10,29]]},"assertion":[{"value":"2021-12-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}